Home › Funds › Geode Capital Management › FDMT
Geode Capital Management position in FDMT
4D MOLECULAR THERAPEUTICS IN · Health Care
Latest position (Q2 2026)1.13M sh
Reported value held$15.01M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 342.22K | $9.23M | New |
| Q4 2021 | 482.44K | $10.58M | Add |
| Q1 2022 | 478.62K | $7.24M | Reduce |
| Q2 2022 | 492.82K | $3.44M | Add |
| Q3 2022 | 528.94K | $4.25M | Add |
| Q4 2022 | 561.74K | $12.48K | Add |
| Q1 2023 | 577.92K | $9.93M | Add |
| Q2 2023 | 689.78K | $12.46M | Add |
| Q3 2023 | 741.66K | $9.44M | Add |
| Q4 2023 | 778.16K | $15.77M | Add |
| Q1 2024 | 872.66K | $27.81M | Add |
| Q2 2024 | 1.06M | $22.27M | Add |
| Q3 2024 | 1.04M | $11.21M | Reduce |
| Q4 2024 | 1.01M | $5.64M | Reduce |
| Q1 2025 | 963.27K | $3.11M | Reduce |
| Q2 2025 | 918.53K | $3.41M | Reduce |
| Q3 2025 | 913.52K | $7.94M | Reduce |
| Q4 2025 | 1.01M | $7.59M | Add |
| Q1 2026 | 1.07M | $9.92M | Add |
| Q2 2026 | 1.13M | $15.01M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding FDMT
- BlackRock Inc 4.55M sh · $60.46M · Q2 2026
- Goldman Sachs Group 4.26M sh · $56.64M · Q2 2026
- Janus Henderson Group 5.25M sh · $48.87M · Q1 2026
- Vanguard Group 3.09M sh · $23.20M · Q4 2025
- Bank of America Corp 1.12M sh · $14.90M · Q2 2026
- Deutsche Bank AG 710.94K sh · $9.46M · Q2 2026
- Renaissance Technologies 614.57K sh · $8.17M · Q2 2026
- Northern Trust Corp 562.93K sh · $7.49M · Q2 2026
- Morgan Stanley 503.02K sh · $6.69M · Q2 2026
- JPMorgan Chase & Co 402.14K sh · $5.18M · Q2 2026
- Charles Schwab Investment Management 339.27K sh · $4.51M · Q2 2026